Ioanna Lazana (I Lazana)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Topics

Stem Cell Transplantation

Systemic Sclerosis

Top Venues

International journal of molecular sciences

Bone marrow transplantation

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Dionysios Vythoulkas, Ioanna Lazana, Christos Kroupis, Eugenia Gkaliagkousi, Ioannis Konstantellos, Zoi Bousiou, Spiros Chondropoulos, Marianna Griniezaki, Anna Vardi, Konstantinos Gkirkas, Aggeliki Karagiannidou, Ioannis Batsis, Maria Stamouli, Ioanna Sakellari, Panagiotis Tsirigotis
Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor. International journal of molecular sciences 24 (8) (2023)
Ioanna Lazana
Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand. International journal of molecular sciences 24 (2) (2023)
Dionysios Vythoulkas, Panagiotis Tsirigotis, Marianna Griniezaki, Ioannis Konstantellos, Ioanna Lazana
Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation. Cancers 15 (3) (2023)
Dionysios Vythoulkas, Ioanna Lazana, Christos Kroupis, Eugenia Gkaliagkousi, Ioannis Konstantellos, Zoi Bousiou, Spiros Chondropoulos, Marianna Griniezaki, Anna Vardi, Konstantinos Gkirkas, Aggeliki Karagiannidou, Ioannis Batsis, Maria Stamouli, Ioanna Sakellari, Panagiotis Tsirigotis
Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor. International journal of molecular sciences 24 (8) (2023)
Ioanna Lazana
Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand. International journal of molecular sciences 24 (2) (2023)
Ioanna Lazana
Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand. International journal of molecular sciences 24 (2) (2023)
Ioanna Lazana
Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand. International journal of molecular sciences 24 (2) (2023)
Dionysios Vythoulkas, Ioanna Lazana, Christos Kroupis, Eugenia Gkaliagkousi, Ioannis Konstantellos, Zoi Bousiou, Spiros Chondropoulos, Marianna Griniezaki, Anna Vardi, Konstantinos Gkirkas, Aggeliki Karagiannidou, Ioannis Batsis, Maria Stamouli, Ioanna Sakellari, Panagiotis Tsirigotis
Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor. International journal of molecular sciences 24 (8) (2023)
Dionysios Vythoulkas, Panagiotis Tsirigotis, Marianna Griniezaki, Ioannis Konstantellos, Ioanna Lazana
Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation. Cancers 15 (3) (2023)
Ioanna Lazana, Sean Apap Mangion, Selma Babiker, Joanna Large, Roochi Trikha, Mark Zuckerman, Shreyans Gandhi, Austin G Kulasekararaj
The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria. International journal of molecular sciences 24 (11) (2023)
Ioanna Lazana, Constantinos Anagnostopoulos
A Novel, Cell-Free Therapy to Enter Our Hearts: The Potential Role of Small EVs in Prevention and Treatment of CVD. International journal of molecular sciences 23 (7) (2022)
Ioanna Lazana, L Floro, T Christmas, Sapna Shah, Kate Bramham, K Cuthill, Paul Bassett, S Schey, M Kazmi, V Potter, A Pagliuca, M Streetly, R Benjamin
Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option. Bone marrow transplantation 57 (6) (2022)
Ioanna Lazana
Extracellular Vesicles in Haematological Disorders: A Friend or a Foe? International journal of molecular sciences 23 (17) (2022)
Ioanna Lazana, George Vassilopoulos
A 'waste product' to save the day in the field of transplantation: The evolving potential of extracellular vesicles. Immunology 167 (2) (2022)
Ioanna Lazana, Azim Mohamedali, Frances Smith, Hugues de Lavallade, Donal P McLornan, Kavita Raj
Uniparental disomy (UPD) of a novel bisphosphoglycerate mutase (BPGM) mutation leading to erythrocytosis. British journal of haematology 192 (1) (2020)